14-99699891-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_006668.2(CYP46A1):c.357-124G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.151 in 669,090 control chromosomes in the GnomAD database, including 7,995 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as protective (no stars).
Frequency
Genomes: 𝑓 0.15 ( 1736 hom., cov: 31)
Exomes 𝑓: 0.15 ( 6259 hom. )
Consequence
CYP46A1
NM_006668.2 intron
NM_006668.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.42
Genes affected
CYP46A1 (HGNC:2641): (cytochrome P450 family 46 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum protein is expressed in the brain, where it converts cholesterol to 24S-hydroxycholesterol. While cholesterol cannot pass the blood-brain barrier, 24S-hydroxycholesterol can be secreted in the brain into the circulation to be returned to the liver for catabolism. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 14-99699891-G-A is Benign according to our data. Variant chr14-99699891-G-A is described in ClinVar as [protective]. Clinvar id is 1693592.Status of the report is no_assertion_criteria_provided, 0 stars. We mark this variant Likely_benign, oryginal submission is: [protective].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.164 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP46A1 | NM_006668.2 | c.357-124G>A | intron_variant | ENST00000261835.8 | NP_006659.1 | |||
CYP46A1 | XM_011536364.2 | c.357-124G>A | intron_variant | XP_011534666.1 | ||||
CYP46A1 | XM_017020933.3 | c.243-124G>A | intron_variant | XP_016876422.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP46A1 | ENST00000261835.8 | c.357-124G>A | intron_variant | 1 | NM_006668.2 | ENSP00000261835 | P1 | |||
CYP46A1 | ENST00000554611.5 | c.*109-124G>A | intron_variant, NMD_transcript_variant | 1 | ENSP00000451069 | |||||
CYP46A1 | ENST00000380228.6 | c.66-124G>A | intron_variant | 2 | ENSP00000369577 |
Frequencies
GnomAD3 genomes AF: 0.152 AC: 23021AN: 151942Hom.: 1737 Cov.: 31
GnomAD3 genomes
AF:
AC:
23021
AN:
151942
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.151 AC: 77817AN: 517030Hom.: 6259 AF XY: 0.151 AC XY: 40598AN XY: 268860
GnomAD4 exome
AF:
AC:
77817
AN:
517030
Hom.:
AF XY:
AC XY:
40598
AN XY:
268860
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.152 AC: 23052AN: 152060Hom.: 1736 Cov.: 31 AF XY: 0.152 AC XY: 11266AN XY: 74350
GnomAD4 genome
AF:
AC:
23052
AN:
152060
Hom.:
Cov.:
31
AF XY:
AC XY:
11266
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
546
AN:
3478
ClinVar
Significance: protective
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Pulmonary disease, chronic obstructive, susceptibility to Benign:1
protective, no assertion criteria provided | research | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | May 11, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at